Arthropod-Borne Viral Infection Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

Arthropod-Borne Viral Infection Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

Arthropod-Borne Viral Infection Testing Trends and Forecast

The future of the global arthropod-borne viral infection testing market looks promising with opportunities in the hospital, research center, and diagnostic center markets. The global arthropod-borne viral infection testing market is expected to grow with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are rapid rise in public health spending, increase in R&D efforts and an increase in the prevalence of arbovirus illnesses, as well as, growth in the diagnostics' suitability for different infections.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Arthropod-Borne Viral Infection Testing by Segment

The study includes a forecast for the global arthropod-borne viral infection testing by test type, disease type, end use, and region.

Arthropod-Borne Viral Infection Testing Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

• ELISA Based Tests
• RT-PCR Based Tests
• Others

Arthropod-Borne Viral Infection Testing Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

• Dengue
• Chikungunya
• St. Louis Encephalitis
• Yellow Fever
• California Encephalitis
• Eastern Equine Encephalitis
• Powassan
• West Nile
• Zika

Arthropod-Borne Viral Infection Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospital
• Research Centers
• Diagnostic Centers
• Others

Arthropod-Borne Viral Infection Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Arthropod-Borne Viral Infection Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies arthropod-borne viral infection testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the arthropod-borne viral infection testing companies profiled in this report include-

• Agilent Technologies
• ThermoFisher Scientific
• NovaTec Immundiagnostica
• Euro immune
• Abbott Laboratories
• Bio-Rad
• Merck

Arthropod-Borne Viral Infection Testing Market Insights

Lucintel forecasts that RT-PCR based test will remain the larger segment over the forecast period.

Within this market, hospital is expected to witness the highest growth due to increasing cases of viral infection.

North America will remain the largest region over the forecast period due to increasing healthcare spending and widespread adoption of technologically advanced products in the region.

Features of the Global Arthropod-Borne Viral Infection Testing Market

Market Size Estimates: Arthropod-borne viral infection testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Arthropod-borne viral infection testing market size by test type, disease type, end use, and region in terms of value ($B).

Regional Analysis: Arthropod-borne viral infection testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test type, disease type, end use, and regions for the arthropod-borne viral infection testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the arthropod-borne viral infection testing market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the growth forecast for arthropod-borne viral infection testing market?

Answer: The global arthropod-borne viral infection testing market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the arthropod-borne viral infection testing market?

Answer: The major drivers for this market are rapid rise in public health spending, increase in R&D efforts and an increase in the prevalence of arbovirus illnesses, as well as, growth in the diagnostics' suitability for different infections.

Q3. What are the major segments for arthropod-borne viral infection testing market?

Answer: The future of the global arthropod-borne viral infection testing market looks promising with opportunities in the hospital, research center, and diagnostic center markets.

Q4. Who are the key arthropod-borne viral infection testing market companies?

Answer: Some of the key arthropod-borne viral infection testing companies are as follows:

• Agilent Technologies
• ThermoFisher Scientific
• NovaTec Immundiagnostica
• Euro immune
• Abbott Laboratories
• Bio-Rad
• Merck

Q5. Which arthropod-borne viral infection testing market segment will be the largest in future?

Answer: Lucintel forecasts that RT-PCR based test will remain the larger segment over the forecast period.

Q6. In arthropod-borne viral infection testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing healthcare spending and widespread adoption of technologically advanced products in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the arthropod-borne viral infection testing market by test type (ELISA based tests, RT-PCR based tests, and others), disease type (dengue, chikungunya, St. louis encephalitis,, yellow fever, California encephalitis, eastern equine encephalitis, powassan, West Nile, and zika), end use (hospital, research centers, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Please note: It will take 2-3 business days to deliver the report upon receipt the order.